CASI PHARMACEUTICALS, INC. Finite-Lived Intangible Assets, Gross
CASI PHARMACEUTICALS, INC. had Finite-Lived Intangible Assets, Gross of $16.08 million as of 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2023-04-26
- 2022-12-31: Finite-Lived Intangible Assets, Gross $16.08M.
- 2021-12-31: Finite-Lived Intangible Assets, Gross $16.03M.
- 2021-09-30: Finite-Lived Intangible Assets, Gross $16.03M.
- 2021-06-30: Finite-Lived Intangible Assets, Gross $16.03M.
| Period end | Finite-Lived Intangible Assets, Gross |
|---|---|
| 2022-12-31 | $16.08M 20-F · filed 2023-04-26 |
| 2021-12-31 | $16.03M 20-F · filed 2023-04-26 |
| 2021-09-30 | $16.03M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $16.03M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $16.03M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $16.03M 10-K · filed 2022-03-28 |
| 2020-09-30 | $16.16M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $18.44M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $20.25M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $20.25M 10-K · filed 2020-03-16 |
| 2019-09-30 | $20.20M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $20.28M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $20.04M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $20.09M 10-K · filed 2019-03-29 |